Sign in
Companies / RVTY vs ILMN

RVTY vs ILMN: Revvity and Illumina

Life Sciences Tools
Compare more companies

Revvity (RVTY) reported $2.9B in revenue against a 8.4% net margin, while Illumina (ILMN) reported $4.3B at a 19.6% net margin, most recently.

MetricRVTYILMN
Revenue$2.9B$4.3B
Net Income$0.2B$0.8B
Gross Margin—66.1%
Operating Margin12.5%18.6%
EPS (Diluted)$2.07$5.45
Free Cash Flow$0.5B$0.9B
Total Debt$3.2B$2.0B
P/E Ratio46.7×24.8×
P/B Ratio1.5×7.6×
Stock Price$150.88$207.96
Free: last 5 years
Fiscal yearFY2008 🔒FY2010 🔒FY2011 🔒FY2012 🔒FY2013 🔒FY2014 🔒FY2016 🔒FY2017 🔒FY2018 🔒FY2019 🔒FY2021FY2022FY2023FY2024FY2025
RVTY Revenue••••••••••••••••••••••••••••••••••••••••••••••••••$3.8B$3.8B$2.8B$2.8B$2.9B
ILMN Revenue••••••••••••••••••••••••••••••••••••••••••••••••••$3.2B$4.5B$4.5B$4.4B$4.3B

More on RVTY

More on ILMN

Other comparisons